European Parliament does not call for premarket review of IVDs

04/18/2013 | Clinica (subscription required)

In vitro diagnostic products would not be subject to centralized or decentralized premarket approval under a draft report released by the European Parliament on IVD regulation in Europe. Rather, the report calls for improving the system for notified bodies and reinforcing the market oversight and vigilance program, among other recommendations.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI